
In this episode of FemmeHealth Founders, Maryann speaks with Dr. Lara Zibners, co-founder of Calla Lily Clinical Care, about the inadequacies in current drug delivery methods for women's health. Lara shares her personal journey from being a physician to an entrepreneur, driven by her own experiences with infertility and the challenges of existing treatments. With a broad background in clinical medicine and medical education in both the US and UK, Lara brings a unique understanding to Calla Lily of the scientific, systematic and business challenges facing women’s healthcare.-----------Current methods of vaginal drug delivery are profoundly inadequate for millions of women around the world. Calla Lily has developed a new leak-free vaginal drug delivery platform. It's simple to use (essential when patients have to administer medications themselves) and also helps to alleviate dosage anxiety and other stresses.Innovators in Vaginal Drug Delivery | Calla Lily Clinical Care This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit femmehealthventures.substack.com
Jan 19, 2025
31 min

In this episode of Notes to Selfe, we dive into the fascinating world of women's health innovation with Sebastian Alexander, founder and CEO of VivoSensMedical. We explore the journey of OvulaRing, a groundbreaking technology transforming the way we understand and address female fertility and gynaecological diagnostics.From the legacy of Sebastian's father-in-law, a pioneer in IVF and reproductive medicine, to the challenges of building a company in an underfunded and often overlooked sector, this episode is a deep dive into the realities of advancing women's health.Together, we discuss:* The unmet needs in women's reproductive health.* How core body temperature is revolutionising fertility diagnostics.* The gender data gap in healthcare and why it matters.* The importance of patient capital in driving women's health innovation.* How value-aligned investors can play a pivotal role in transforming the future of women's health.If you are an investor, founder, or simply someone passionate about advancing healthcare for women, this episode will inspire and inform you.----------VivoSensMedical GmbH is a young, medical company from Leipzig that combines medical-scientific experience, technical know-how, marketing and sales expertise, and management practice. The company's vision is to transfer a wealth of experience of over 40 years of scientific work in clinical and user-friendly products to benefit both patients and doctors. VivoSensMedical strives to set new standards in diagnosis and treatment in the fields of gynaecology, reproductive and sexual medicine, and immunology and autoimmune diseases.vivosensmedical.comOvulaRing cycle tracker - determines your ovulation precisely This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit femmehealthventures.substack.com
Dec 18, 2024
40 min

Hormones rule our lives—from puberty to menopause, they influence everything from our mood to our health. But why do some women experience severe side effects while others don’t?In this episode of the FemmeHealth Founder Series, I sit down with Dr. Paulina Cecula, co-founder of Dama Health, to:📌 explore the groundbreaking science behind personalized hormone therapy.📌 discuss the complex interplay of genetics, metabolism, and microbiome, and why trial-and-error contraception needs to become a thing of the past.If you’re curious about the future of precision medicine in women’s health or simply want to understand your body better, this is an episode you can’t miss.-------------------------Dama Health with consortium partners Nura Health and Lasa Health, have recently been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an awardee of the Sprint for Women’s Health, to address critical unmet challenges in women’s health. Dama Health and its consortium partners will receive $3 million in funding over two years for early stage research efforts.***Disclaimer***All opinions are my own and personal. This is not investment advice. I do not provide any buying or selling recommendations, nor do I offer any investment advice. You are advised to conduct your own research and due diligence when making financial and investment decisions. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit femmehealthventures.substack.com
Nov 20, 2024
29 min
